Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib

References

• Garti N, Avrahami M, Aserin A. Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J Colloid Interface Sci. 2006;299:352–365. doi:10.1016/j.jcis.2006.01.06016529763
   PubMed Web of Science ®Google Scholar
• Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res. 2004;21:1762–1769.15553220
   PubMed Web of Science ®Google Scholar
• Gupta VR, Mutalik S, Patel MM, Jani GK. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm. 2007;57:173–184.17507314
   PubMedGoogle Scholar
• Paulson SK, Vaughn MB, Jessen SM, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther. 2001;297:638–645.11303053
   PubMed Web of Science ®Google Scholar
• Morgen M, Bloom C, Beyerinck R, et al. Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug. Pharm Res. 2012;29:427–440. doi:10.1007/s11095-011-0558-721863477
   PubMed Web of Science ®Google Scholar
• Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull. 2004;27:1993–1999.15577219
   PubMed Web of Science ®Google Scholar
• Kimura T, Imamura H, Hasegawa K, Yoshida A. Mechanisms of toxicities of some detergents added to a diet and of the ameliorating effect of dietary fiber in the rat. J Nutr Sci Vitaminol (Tokyo). 1982;28:483–489.6298391
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175–186. doi:10.1016/j.ejps.2013.02.00623485439
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33:4889–4906. doi:10.1016/j.biomaterials.2012.03.04622498300
   PubMed Web of Science ®Google Scholar
• Yan A, Bussche A, Kane A, Hurt R. Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes. Carbon N Y. 2007;45:2463–2470. doi:10.1016/j.carbon.2007.08.03519081834
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 2005;25:445–453. doi:10.1016/j.ejps.2005.04.00315890503
   PubMed Web of Science ®Google Scholar
• Ho PY, Yeh TK, Yao HT, et al. Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice. Int J Pharm. 2008;359:174–181. doi:10.1016/j.ijpharm.2008.04.01318513900
   PubMed Web of Science ®Google Scholar
• Chang T, Benet LZ, Hebert MF. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther. 1996;59:297–303. doi:10.1016/S0009-9236(96)80007-58653992
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim DW, Kim K, et al. Development of a novel l-sulpiride-loaded quaternary microcapsule: effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability. Colloids Surf B Biointerfaces. 2016;147:250–257. doi:10.1016/j.colsurfb.2016.08.01027518457
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A. Vitamin E-TPGS increases absorption flux of HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 1999;16:1812–1817.10644067
   PubMed Web of Science ®Google Scholar
• Zhu L, Lu L, Wang S, et al. Oral absorption basics: pathways and physicochemical and biological factors affecting absorption In: Qiu Y, Chen Y, Zhang GGZ, Mantri RV, Yu L, editors. Developing Solid Oral Dosage Forms. 2nd ed. London, UK: Academic Press; 2017:297–329.
   Google Scholar
• Xing Q, Song J, You X, et al. Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously. Int J Pharm. 2016;511:709–718. doi:10.1016/j.ijpharm.2016.07.06127473280
   PubMedGoogle Scholar
• Tang TT, Hu XB, Liao DH, Liu XY, Xiang DX. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Int J Nanomedicine. 2013;8:4415–4426. doi:10.2147/IJN.S5146924277986
   PubMed Web of Science ®Google Scholar
• Nolte K, Backfisch G, Neidlein R. In vitro studies of poorly absorbed drugs using porcine intestine in the ring model RIMO. Arzneimittelforschung. 2000;50:664–668. doi:10.1055/s-0031-130026910965427
   PubMedGoogle Scholar
• Westerhout J, van de Steeg E, Grossouw D, et al. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci. 2014;63:167–177. doi:10.1016/j.ejps.2014.07.00325046168
   PubMed Web of Science ®Google Scholar
• Subongkot T, Ngawhirunpat T. Development of a novel microemulsion for oral absorption enhancement of all-trans retinoic acid. Int J Nanomedicine. 2017;12:5585–5599. doi:10.2147/IJN.S14250328831254
   PubMed Web of Science ®Google Scholar
• Bader CA, Shandala T, Carter EA, et al. A molecular probe for the detection of polar lipids in live cells. PLoS One. 2016;11:e0161557. doi:10.1371/journal.pone.016155727551717
   PubMedGoogle Scholar
• Ke WT, Lin SY, Ho HO, Sheu MT. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. J Control Release. 2005;102:489–507. doi:10.1016/j.jconrel.2004.10.03015653166
   PubMed Web of Science ®Google Scholar
• Acharya DP, Hartley PG. Progress in microemulsion characterization. Curr Opin Colloid Interface Sci. 2012;17:274–280.
   Web of Science ®Google Scholar
• Callender SP, Mathews JA, Kobernyk K, Wettig SD. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017;526:425–442. doi:10.1016/j.ijpharm.2017.05.00528495500
   PubMed Web of Science ®Google Scholar
• Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci. 2006;128–130:47–64. doi:10.1016/j.cis.2006.11.016
   PubMed Web of Science ®Google Scholar
• Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm. 2013;453:569–578. doi:10.1016/j.ijpharm.2013.06.00923792042
   PubMed Web of Science ®Google Scholar
• Zhao JH, Ji L, Wang H, et al. Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo. Int J Nanomedicine. 2011;6:1611–1619. doi:10.2147/IJN.S2359721904451
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2012;64:175–193. doi:10.1016/j.addr.2012.09.018
   Web of Science ®Google Scholar
• Krauel K, Davies NM, Hook S, Rades T. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization. J Control Release. 2005;106:76–87. doi:10.1016/j.jconrel.2005.04.01315967536
   PubMed Web of Science ®Google Scholar
• Djekic L, Primorac M, Filipic S, Agbaba D. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions. Int J Pharm. 2012;433:25–33. doi:10.1016/j.ijpharm.2012.04.07022579578
   PubMedGoogle Scholar
• Panapisal V, Charoensri S, Tantituvanont A. Formulation of microemulsion systems for dermal delivery of silymarin. AAPS PharmSciTech. 2012;13:389–399. doi:10.1208/s12249-012-9762-y22350738
   PubMed Web of Science ®Google Scholar
• Cavalcanti AL, Reis MY, Silva GC, et al. Microemulsion for topical application of pentoxifylline: in vitro release and in vivo evaluation. Int J Pharm. 2016;506:351–360. doi:10.1016/j.ijpharm.2016.04.06527130362
   PubMed Web of Science ®Google Scholar
• Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. Pstt. 2000;3:346–358.
   PubMedGoogle Scholar
• Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778:588–600. doi:10.1016/j.bbamem.2007.08.01717916321
   PubMed Web of Science ®Google Scholar
• Ates M, Kaynak MS, Sahin S. Effect of permeability enhancers on paracellular permeability of acyclovir. J Pharm Pharmacol. 2016;68:781–790. doi:10.1111/jphp.1255127061718
   PubMedGoogle Scholar
• Yu Q, Wang Z, Li P, Yang Q. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line. Drug Dev Ind Pharm. 2013;39:587–592. doi:10.3109/03639045.2012.69237622656319
   PubMed Web of Science ®Google Scholar
• Kowapradit J, Opanasopit P, Ngawhirunpat T, Rojanarata T, Ruktanonchai U, Sajomsang W. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells. Drug Deliv. 2010;17:301–312. doi:10.3109/1071754100370627320302396
   PubMed Web of Science ®Google Scholar
• Canaparo R, Finnström N, Serpe L, et al. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum. Clin Exp Pharmacol Physiol. 2007;34:1138–1144. doi:10.1111/j.1440-1681.2007.04691.x17880367
   PubMed Web of Science ®Google Scholar
• Bogman K, Zysset Y, Degen L, et al. P-glycoprotein and surfactants: effecton intestinal talinolol absorption. Clin Pharmacol Ther. 2005;77:24–32. doi:10.1016/j.clpt.2004.09.00115637528
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm. 2007;4:465–474. doi:10.1021/mp060121r17367162
   PubMed Web of Science ®Google Scholar